Micaletto S - Search Results

1

Urticaria and Angioedema: an Update on Classification and Pathogenesis.

Radonjic-Hoesli S, Hofmeier KS, Micaletto S, Schmid-Grendelmeier P, Bircher A, Simon D. Radonjic-Hoesli S, et al. Among authors: micaletto s. Clin Rev Allergy Immunol. 2018 Feb;54(1):88-101. doi: 10.1007/s12016-017-8628-1. Clin Rev Allergy Immunol. 2018. PMID: 28748365 Free article. Review.

2

Risk factors for severe systemic sting reactions in wasp (Vespula spp.) and honeybee (Apis mellifera) venom allergic patients.

Fehr D, Micaletto S, Moehr T, Schmid-Grendelmeier P. Fehr D, et al. Among authors: micaletto s. Clin Transl Allergy. 2019 Oct 11;9:54. doi: 10.1186/s13601-019-0292-5. eCollection 2019. Clin Transl Allergy. 2019. PMID: 31632639 Free PMC article.

3

Honey bee venom re-challenge during specific immunotherapy: prolonged cardio-pulmonary resuscitation allowed survival in a case of near fatal anaphylaxis.

Micaletto S, Ruetzler K, Bruesch M, Schmid-Grendelmeier P. Micaletto S, et al. Allergy Asthma Clin Immunol. 2022 Jun 2;18(1):44. doi: 10.1186/s13223-022-00687-x. Allergy Asthma Clin Immunol. 2022. PMID: 35655287 Free PMC article.

4

Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma.

Dimitriou F, Matter AV, Mangana J, Urosevic-Maiwald M, Micaletto S, Braun RP, French LE, Dummer R. Dimitriou F, et al. Among authors: micaletto s. J Immunother. 2019 Jan;42(1):29-32. doi: 10.1097/CJI.0000000000000236. J Immunother. 2019. PMID: 29939877 Free article.

5

Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma.

Dimitriou F, Mangana J, Micaletto S, Braun RP, Dummer R. Dimitriou F, et al. Among authors: micaletto s. Melanoma Res. 2019 Feb;29(1):107-108. doi: 10.1097/CMR.0000000000000544. Melanoma Res. 2019. PMID: 30557221 Free article. No abstract available.

6

Long-Term Response to Intermittent Binimetinib in Patients with NRAS-Mutant Melanoma.

Matter AV, Micaletto S, Urner-Bloch U, Dummer R, Goldinger SM. Matter AV, et al. Among authors: micaletto s. Oncologist. 2020 Nov;25(11):e1593-e1597. doi: 10.1634/theoncologist.2019-0656. Epub 2020 Sep 21. Oncologist. 2020. PMID: 32886824 Free PMC article.

7

Binimetinib in heavily pretreated patients with NRAS-mutant melanoma with brain metastases.

Goldinger SM, Valeska Matter A, Urner-Bloch U, Narainsing J, Micaletto S, Blume I, Mangana J, Dummer R. Goldinger SM, et al. Among authors: micaletto s. Br J Dermatol. 2020 Feb;182(2):488-490. doi: 10.1111/bjd.18449. Epub 2019 Oct 9. Br J Dermatol. 2020. PMID: 31436845 No abstract available.

8

Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 Therapy.

Goldinger SM, Stieger P, Meier B, Micaletto S, Contassot E, French LE, Dummer R. Goldinger SM, et al. Among authors: micaletto s. Clin Cancer Res. 2016 Aug 15;22(16):4023-9. doi: 10.1158/1078-0432.CCR-15-2872. Epub 2016 Mar 8. Clin Cancer Res. 2016. PMID: 26957557 Free article.

9

The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe.

Dimitriou F, Krattinger R, Ramelyte E, Barysch MJ, Micaletto S, Dummer R, Goldinger SM. Dimitriou F, et al. Among authors: micaletto s. Curr Oncol Rep. 2018 Sep 24;20(11):87. doi: 10.1007/s11912-018-0732-8. Curr Oncol Rep. 2018. PMID: 30250984 Review.

10

How I treat metastatic melanoma.

Dummer R, Mangana J, Frauchiger AL, Lang C, Micaletto S, Barysch MJ. Dummer R, et al. Among authors: micaletto s. ESMO Open. 2019 Jul 21;4(Suppl 2):e000509. doi: 10.1136/esmoopen-2019-000509. eCollection 2019. ESMO Open. 2019. PMID: 31423341 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page